• 1
    Anonymous (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—The evidence report. National Institutes of Health [published erratum appears in Obes Res 1998;6:464]. Obes Res. (Suppl 2), 51S209S.
  • 2
    Taubes, G. (1998) As obesity rates rise, experts struggle to explain why. Science 280: 13671368.
  • 3
    Wickelgren, I. (1998) Obesity: how big a problem? Science 280: 13641367.
  • 4
    Anonymous (1998) Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 158: 18551867.
  • 5
    Quesenberry, C. P. J., Caan, B., Jacobson, A. (1998) Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med 158: 466472.
  • 6
    Henry, R. R., Wallace, P., Olefsky, J. M. (1986) Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes 35: 990998.
  • 7
    Uusitupa, M. I., Laakso, M., Sarlund, H., Majander, H., Takala, J., Penttila, I. (1990) Effects of a very-low-calorie diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics. Am J Clin Nutr 51: 768773.
  • 8
    Wing, R. R., Koeske, R., Epstein, L. H., Nowalk, M. P., Gooding, W., Becker, D. (1987) Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 147: 17491753.
  • 9
    Rabkin, S. W., Boyko, E., Wilson, A., Streja, D. A. (1983) A randomized clinical trial comparing behavior modification and individual counseling in the nutritional therapy of non-insulin-dependent diabetes mellitus: comparison of the effect on blood sugar, body weight, and serum lipids. Diabetes Care 6: 5056.
  • 10
    Willey, K. A., Molyneaux, L. M., Yue, D. K. (1994) Obese patients with type 2 diabetes poorly controlled by insulin and metformin: effects of adjunctive dexfenfluramine therapy on glycaemic control. Diabetic Med 11: 701704.
  • 11
    Capstick, F., Brooks, B. A., Burns, C. M., et al (1997) Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient. Diabetes Res Clin Pract 36: 105111.
  • 12
    Stewart, G. O., Stein, G. R., Davis, T. M., Findlater, P. (1993) Dexfenfluramine in type II diabetes: effect on weight and diabetes control. Med J Aust 158: 167169.
  • 13
    Henry, R. R., Wiest-Kent, T. A., Scheaffer, L., Kolterman, O. G., Olefsky, J. M. (1986) Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes 35: 155164.
  • 14
    Guare, J. C., Wing, R. R., Grant, A. (1995) Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss. Obes Res 3: 329335.
  • 15
    Jackson, R. A., Moloney, M., Lowy, C., et al (1971) Differences between metabolic responses to fasting in obese diabetic and obese nondiabetic subjects. Diabetes 20: 214227.
  • 16
    Wing, R. R., Marcus, M. D., Epstein, L. H., Salata, R. (1987) Type II diabetic subjects lose less weight than their overweight nondiabetic spouses. Diabetes Care 10: 563566.
  • 17
    Schutz, Y., Golay, A., Felber, J. P., Jequier, E. (1984) Decreased glucose-induced thermogenesis after weight loss in obese subjects: a predisposing factor for relapse of obesity? Am J Clin Nutr 39: 380387.
  • 18
    Lean, M. E., Powrie, J. K., Anderson, A. S., Garthwaite, P. H. (1990) Obesity, weight loss and prognosis in type 2 diabetes. Diabetic Med 7: 228233.
  • 19
    Ravussin, E., Bogardus, C., Schwartz, R. S., et al (1983) Thermic effect of infused glucose and insulin in man: decreased response with increased insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Invest 72: 893902.
  • 20
    Saltiel, A. R., Olefsky, J. M. (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 16611669.
  • 21
    Hartley, G. G., Nicol, S., Halstenson, C., Khan, M., Pheley, A., St. Peter, J. V. (1997) Long-term results from phentermine, fenfluramine, diet, behavior modification, and exercise for treatment of obesity. Obes Res 5: 58S (abstr.).
  • 22
    Kilo, C., Meenan, A., Bloomgarden, Z. (1992) Glyburide versus glipizide in the treatment of patients with non-insulin-dependent diabetes mellitus. Clin Ther 14: 801812.
  • 23
    Alexis, G., Henault, R., Sparr, H. B. (1992) Conversion from glipizide to glyburide: a prospective cost-impact survey. Clin Ther 14: 409417.
  • 24
    Khan, M. A., Herzog, C. A., St. Peter, J. V., et al (1998) The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med 339: 713718.
  • 25
    Khan, M. A., St. Peter, J. V., Herzog, C. A., Hartley, G. G. (1998) Appetite suppressant-related valvulopathy in obese diabetic and nondiabetic individuals. Diabetes 47: A311 (abstr.).
  • 26
    Murray, D. C. (1975) Treatment of overweight: I. Relationship between initial weight and weight change during behavior therapy of overweight individuals: analysis of data from previous studies. Psychol Rep 37: 243248.
  • 27
    Wing, R. R., Shoemaker, M., Marcus, M. D., McDermott, M., Gooding, W. (1990) Variables associated with weight loss and improvements in glycemic control in type II diabetic patients in behavioral weight control programs. Int J Obes 14: 495503.
  • 28
    Feldman, J. M., Lebovitz, F. L. (1973) Tests for glucosuria: an analysis of factors that cause misleading results. Diabetes 22: 115121.
  • 29
    Golay, A., Swislocki, A. L., Chen, Y. D., Reaven, G. M. (1987) Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism 36: 692696.
  • 30
    Goldner, M. G., Knatterud, G. L., Prout, T. E. (1971) Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results. JAMA 218: 14001410.